Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio in the U.S., expanding patient choice and streamlining diabetes care workflows. PALO ALTO, ...
24/7 Wall St. on MSN
Abbott Labs vs. Danaher: Abbott’s everyday products beat Danaher’s slumping biotech equipment
Quick ReadAbbott (ABT) outpaced Danaher (DHR) as FreeStyle Libre delivered $2.08B while Cepheid respiratory revenue fell 25% on a soft flu season.Danaher's bioprocessing equipment orders surged over ...
Some FreeStyle Libre 3 glucose sensors made by Abbott Diabetes Care may give incorrect low readings. The devices have been ...
Pharmaceutical and med device giant Abbott (NYSE: ABT) said today that it had received approval from the Food and Drug Administration (FDA) for its next-generation integrated continuous glucose ...
The little white disc glucose sensor worn on the arm known as the Abbott FreeStyle Libre came to the continuous glucose monitoring (CGM) market years ago with a handheld scanner, requiring users to ...
The FreeStyle Libre 3 glucose monitoring system (Abbott) has been granted a CE mark for use by people with diabetes in the countries of the European Union (EU). The next-generation FreeStyle Libre 3 ...
Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's issuing a voluntary medical device correction for some of its FreeStyle ...
FreeStyle Libre is a continuous glucose monitoring (CGM) system that allows a person to monitor their blood sugar levels in real time without finger pricks. It uses a sensor applied to the skin and a ...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that the t:slim X2™ insulin pump with Control-IQ+ TM automated insulin delivery ...
The US Food and Drug Administration (FDA) has tagged Abbott's recent recall of its faulty FreeStyle Libre 3 sensors as Class I, the most serious designation the agency can hand out for a recall. The ...
Abbott has launched an effort to replace some of its FreeStyle Libre 3 continuous glucose monitors—following reports of hundreds of injuries and seven deaths worldwide—after some sensors showed they ...
Abbott Laboratories (NYSE:ABT) is a stock with characteristics suited to multi-decade ownership, because its four-segment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results